For Immediate Release
Wednesday, September 24, 2008
Penn Researcher Receives $1 Million Grant for Cancer Gene Therapy Research
PHILADELPHIA - Carl
June, MD, Director of Translational Research at the Abramson Cancer Center of the University of
Pennsylvania and Professor of Pathology and Laboratory Medicine in
Penns School of Medicine, has
received $1 million over the next three years from the Alliance for Cancer Gene
Therapy, Inc. (ACGT) to harness the immune system to fight the worst cases of
As the only national foundation devoted exclusively to funding cancer gene therapy research, the mission of ACGT is to identify and fund innovative scientific research on the causes, treatment, and prevention of all types of cancer, using cells and genes as medicine. The award is entitled The Joan Miller and Linda Bernstein Gene Therapy Ovarian Cancer Award.
Ovarian cancer is the leading cause of gynecologic cancer death, and though most patients respond to initial chemotherapy, the majority will eventually relapse and die of chemotherapy-resistant disease. Despite the advent of newer chemotherapies, the five-year survival for patients with advanced disease remains only 25 percent, and few patients are cured.
With this grant from the
June was selected by ACGTs 12-member Scientific Advisory Council, which includes some of the nations most preeminent physicians and researchers in cancer gene therapy.
This release can also be found at: www.uphs.upenn.edu/news.
Medicine is a $3.5 billion enterprise
dedicated to the related missions of medical education, biomedical research, and
excellence in patient care. PENN Medicine consists of the
The University of Pennsylvania Health System includes three hospitals its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nations top 10 Honor Roll hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.
Cancer Center (ACC) of the University of
Pennsylvania is a national leader in cancer
research, patient care, and education. The pre-eminent position of the